14.43000 EUR
0.415
2.80%
Last update Dec 16, 7:37 PM CET
Market closed
Day range
14.40000
14.66000
Previous close
14.84500
Open
14.64000
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
14.43
0.42
2.80%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 86.9M 87.5M 99.1M 85.0M
Selling general and admin 30.2M 27.5M 25.0M 25.6M
Other operating expenses
Operating income -117.1M -115.0M -124.1M -110.7M
Non operating interest income
Income 9.0M 9.2M 10.7M 12.9M
Expense
Other income expense 0
Pretax income -108.2M -105.8M -113.3M -97.7M
Tax provision
Net income -108.2M -105.8M -113.3M -97.8M
Basic EPS -0.7 -0.8 -0.7
Diluted EPS -0.7 -0.8 -0.7
Basic average shares 146.1M 145.9M 145.0M
Diluted average shares 146.1M 145.9M 145.0M
EBITDA -113.8M -111.7M -121.3M -108.4M
Net income from continuing op. -108.2M -105.8M -113.3M -97.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 15 minutes

07:44
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).